Correction: Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India
- PMID: 40184380
- PMCID: PMC11970649
- DOI: 10.1371/journal.pone.0322153
Correction: Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0272042.].
Copyright: © 2025 Ponnaiah et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Erratum for
-
Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India.PLoS One. 2022 Aug 8;17(8):e0272042. doi: 10.1371/journal.pone.0272042. eCollection 2022. PLoS One. 2022. PMID: 35939442 Free PMC article.
References
-
- Ponnaiah M, Ganesan S, Bhatnagar T, Thulasingam M, Majella MG, Karuppiah M, et al.. Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India. PLoS One. 2022;17(8): e0272042. doi: 10.1371/journal.pone.0272042 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources